FDA Holds Hearings to Pull Avandia
The US Food and Drug Administration just opened two days of hearings into the safety of Avanida, a once-popular type 2 diabetes drug manufactured by drug giant, GlaxoSmithKline. Avandia has been on the market for years and is still being prescribed despite an FDA-issued black box warning (the most stern warning a drug can receive) that the drug leads to serious cardiac issues in patients taking the drug for their diabetes. It has been estimated that 100,000 heart attacks have been linked to the drug. In the last part of 2009, it is estimated that 300 people died due to Avandia complications. US Senate reports indicate that Glaxo may have been well aware of the increased risk of heart attacks associated with the drug but sought to suppress that information. Now thousands of lives have been affected.
As early as tomorrow, the panel, made up of 33 people, could vote on whether or not to remove the drug from the market altogether. Glaxo insists the drug is safe despite the evidence showing it is not.
According to Montana Senator Max Baucus, “Americans have a right to know there are serious health risks associated with Avandia and GlaxoSmithKline had a responsibility to tell them. Patients trust drug companies with their health and their lives and GlaxoSmithKline abused that trust.”
If you or a loved one has suffered from a dangerous drug, please contact the pharmaceutical liability attorneys at Schlichter, Bogard & Denton today to schedule a confidential, no-cost consultation.